Mice with targeted GIPR-deficiency to immune cells exhibit a deteriorated metabolic profile and significant myelopoiesis, concomitantly with impaired energy expenditure and ingWAT beiging under the setting of HFD-induced obesity (13). The gene discussed is GIPR; the disease is obesity disorder.